Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VivoSight Dx Topical OCT System

K-Number: K153283 · 2016-08-11

Decision Date2016-08-11
Product CodeNQQ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

VivoSight Dx Topical OCT System is a medical device manufactured by Michelson Diagnostics, Ltd.. It received FDA 510(k) clearance on 2016-08-11 under approval number K153283. The device is classified under product code NQQ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VivoSight Dx Topical OCT System?

VivoSight Dx Topical OCT System is a medical device that received FDA 510(k) clearance on 2016-08-11. It is manufactured by Michelson Diagnostics, Ltd.. The 510(k) number is K153283.

When was VivoSight Dx Topical OCT System approved by the FDA?

VivoSight Dx Topical OCT System received FDA 510(k) clearance on 2016-08-11, under approval number K153283.

What company makes VivoSight Dx Topical OCT System?

VivoSight Dx Topical OCT System is manufactured by Michelson Diagnostics, Ltd..

What is the FDA product code for VivoSight Dx Topical OCT System?

The FDA product code for VivoSight Dx Topical OCT System is NQQ.

Related Clinical Trials

Related Devices (Code: NQQ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.